Movement Alert｜Solventum Intraday Rise 5.49% in Regular Trading, Q3 Beat and Raised Outlook Support Shares

Market Focus11-07

On November 7, Solventum rose 5.49% in Regular Trading, trading at $91.95 with turnover of $169 million.

The move was supported by a fresh earnings-driven catalyst, with the company reporting third-quarter adjusted EPS of $1.45 and revenue of $1.949 billion, both above market expectations, while also raising its full-year adjusted EPS guidance.

For the quarter ended September 30, adjusted EPS declined from $1.50 a year earlier and net sales fell from $2.10 billion, but both still topped consensus estimates near $1.34 to $1.35 for EPS and $1.93 billion to $1.935 billion for sales. Solventum lifted full-year adjusted EPS guidance to $7.20 to $7.30 from $7.10 to $7.20, above the $7.15 analyst view. Separately, Piper Sandler increased its price target to $110 from $105, adding support to sentiment. The latest reported average analyst rating remained overweight, with a mean price target of $98.91.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment